Stocks soared today as the monthly jobs report came in above expectations. The Dow Jones Industrial Average (DJINDICES: ^DJI ) finished up 207 points, or 1.4%, to close the week at 15,248.
The Labor Department reported that 175,000 jobs were added in May, better than consensus projections at 159,000. However, the jobs report was not stellar across the board as private-sector jobs only beat estimates by 3,000, and the unemployment rate ticked to 7.6% from 7.5% in April. The Labor Department also revised down its estimate of jobs created in April from 165,000 to 149,000. Given the negatives in the report, the market's reaction seems to be a bit exaggerated.
Boeing (NYSE: BA ) was the biggest winner out of the blue chips, gaining 2.7%, as the aerospace maker was a part of a $4 billion deal announced today that includes Rolls-Royce and Singapore Airlines. According to the agreement, Rolls Royce will provide engines for 50 Boeing 787 jets. The aerospace giant shares have continued to move higher now that its Dreamliner battery fire problems have been resolved. Boeing hit a five-year high today, and shares are up 35% this year.
Best Energy Companies To Invest In Right Now: HomeTrust Bancshares Inc (HTBI)
HomeTrust Bancshares, Inc. is a bank holding company. The Company operates through HomeTrust Bank (the Bank). The Bank is a federally chartered mutual savings bank with 20 retail offices located in North Carolina. The business of the Bank is conducted through its seven operating divisions: HomeTrust Bank, Cherryville Federal Bank, Home Savings Bank of Eden, Industrial Federal Bank of Lexington, Shelby Savings Bank, Tryon Federal Bank and Rutherford County Bank. Its wholly owned subsidiary, Western North Carolina Service Corporation (WNCSC), owns office buildings in Asheville and Hendersonville, North Carolina that are leased to the Bank and several other tenants. Effective July 31, 2013, it announced the completion of its acquisition of BankGreenville Financial Corporation, the holding company for BankGreenville.
Lending activities
The Bank�� loan portfolio is organized into two segments (retail consumer loans and commercial loans) and into four classes within each segment. Its loan portfolio also includes one to four family loans, commercial real estate loans, home equity lines of credit, commercial loans and consumer loans. The Bank underwrites its retail consumer loans using automated credit scoring and analysis tools. These credit scoring tools take into account factors, such as payment history, credit utilization, length of credit history, types of credit in use and recent credit inquiries. One to four family and construction and land/lot loans are to individuals and are typically secured by one-to-four family residential property, undeveloped land, and partially developed land in anticipation of pending construction of a personal residence. Consumer loans include loans secured by deposit accounts or personal property, such as automobiles, boats, and motorcycles, as well as unsecured consumer debt.
The Bank�� commercial loans are centrally underwritten based primarily on the customer�� ability to generate the required cash flow to service the debt in a! ccordance with the contractual terms and conditions of the loan agreement. Real estate owned consists of real estate acquired as a result of customers��loan defaults.
Investment activities
The Company�� investment securities consist of United States Government Agencies, Residential Mortgage-backed Securities of United States Government and Agencies. It also includes Government-Sponsored Enterprises. Securities available for sale were $26.7 million, as of March 31, 2012.
Sources of funds
The Company offers a variety of deposit accounts for individuals, businesses and nonprofit organizations. Deposits are its primary source of funds for lending and investing activities.
Advisors' Opinion:- [By Tim Melvin]
Home Trust Bancshares (HTBI) is another example of a cheap, well-financed community bank that has the potential for strong performance over the next couple of years. While the bank�� nonperforming assets are a little above average at 3.87% of total assets, HTBI has plenty of excess capital. The equity-to-assets ratio is more than 20 as of the end of the third quarter, and HTBI has been using its capital to buy back HTBI shares below book value.
5 Best High Tech Stocks To Invest In Right Now: BioFuel Energy Corp.(BIOF)
BioFuel Energy Corp. produces and sells ethanol and its co-products in the United States. The company offers dried and wet distillers grains with solubles, corn oil, and carbon dioxide. It operates 2 ethanol production facilities located in Wood River, Nebraska and Fairmont, Minnesota with a combined production capacity of approximately 220 million gallons per year. The company sells its products to independent third party marketers and distributors. The company was founded in 2006 and is headquartered in Denver, Colorado.
Advisors' Opinion:- [By Roberto Pedone]
BioFuel Energy (BIOF) is engaged in the production and sale of ethanol and its co-products through its two ethanol production facilities located in Nebraska and Minnesota. This stock closed up 9.4% to $4.04 in Tuesday's trading session.
Tuesday's Range: $3.69-$4.04
52-Week Range: $2.70-$10.75
Tuesday's Volume: 152,000
Three-Month Average Volume: 57,949From a technical perspective, BIOF soared higher here back above its 50-day moving average of $3.76 with above-average volume. This move is quickly pushing shares of BIOF within range of triggering a major breakout trade. That trade will hit if BIOF manages to take out some near-term overhead resistance levels at $3.99 to $4.12 with high volume. At last check, BIOF hit an intraday high of $4.04 and volume was well above its three-month average action of 57,949 shares.
Traders should now look for long-biased trades in BIOF as long as it's trending above its 50-day at $3.76 or above more near-term support at $3.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 57,949 shares. If that breakout hits soon, then BIOF will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day of $4.63 to $5.19. Any high-volume move above $5.19 will then put $5.50 to $6 within range for shares of BIOF.
5 Best High Tech Stocks To Invest In Right Now: Seattle Genetics Inc.(SGEN)
Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Its lead product, SGN-35 is in pivotal trial stage used for the treatment of patients with relapsed or refractory hodgkin lymphoma. The company?s other product candidates in various stages of clinical trials include SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; dacetuzumab (SGN-40), a humanized anti-CD40 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc .; Daiichi Sankyo Co., Ltd.; Genentech, Inc.; GlaxoSmithKline LLC; Millennium; and PSMA Development Company LLC. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc.; and Genmab A/S. Seattle Genetics, Inc. was founded in 1997 and is headquartered in Bothell, Washington.
Advisors' Opinion:- [By Brian Orelli]
Seattle Genetics (NASDAQ: SGEN ) is up in after-hours trading after posting record sales for its blood cancer drug Adcetris, and raising guidance for the year. The biotech sold $48 million worth of Adcetris in the U.S. and Canada, a 32% year-over-year increase.
- [By Lee Jackson]
While very upbeat on the sector as a whole, UBS was very cautious on sell-rated Ironwood Pharmaceuticals, Inc (NASDAQ: IRWD) and ImmunoGen Inc. (NASDAQ: IMGN). Neutral-rated Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Seattle Genetics Inc. (NASDAQ: SGEN) were also viewed with a skeptical eye.
- [By Roberto Pedone]
One biotechnology player that insiders are snapping up a huge amount of stock in here is Seattle Genetics (SGEN), which develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. Insiders are buying this stock into huge strength, since shares are up sharply by 72% so far in 2013.
Seattle Genetics has a market cap of $4.9 billion and an enterprise value of $4.5 billion. This stock trades at a premium valuation, with a price-to-sales of 19.09 and a price-to-book of 21.65. Its estimated growth rate for this year is -37%, and for next year it's pegged at -6.3%. This is a cash-rich company, since the total cash position on its balance sheet is $373.85 million and its total debt is zero.
A director just bought 1,005,901 shares, or about $43.44 million worth of stock, at $42.31 to $43.98 per share.
From a technical perspective, SGEN is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock has been downtrending over the last few weeks, with shares dropping from its high of $45.37 to its intraday low of $39.85 a share. During that move, shares of SGEN have been consistently making lower highs and lower lows, which is bearish technical price action.
If you're bullish on SGEN, then I would look for long-biased trades as long as this stock is trending above its 200-day of $38.40 or above more near-term support at $36.79 and then once it takes out its 50-day at $41.02 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 856,995 shares. If we get that move soon, then SGEN will set up to re-test or possibly take out its next major overhead resistance levels at $45.37 $46.48 a share. Any high-volume move above those levels will then give SGEN a chance to tag its 52-week high at $49.23 a share.
- [By Sean Williams]
These might not be household names in the U.S., but they do brandish global licensing partnerships with companies that might be more familiar to you. Takeda, for example, has licensing agreements in place with Orexigen Therapeutics (NASDAQ: OREX ) , which recently filed a New Drug Application for its chronic weight management (i.e., anti-obesity) pill, Contrave, in the U.S. Takeda owns the right to Contrave outside of North America. In addition, Takeda is a collaborative partner of antibody-drug conjugate developer Seattle Genetics (NASDAQ: SGEN ) with regard to FDA-approved Hodgkin lymphoma drug Adcetris.�
5 Best High Tech Stocks To Invest In Right Now: Hanmi Financial Corporation(HAFC)
Hanmi Financial Corporation operates as the holding company for Hanmi Bank that provides general business banking products and services in the United States. Its deposit product line comprises business and personal checking accounts, savings accounts, negotiable order of withdrawal accounts, money market accounts, and certificates of deposit. The company?s loan portfolio includes real estate loans, such as commercial property, construction, and residential property loans; commercial and industrial loans comprising commercial term loans, commercial lines of credit, small business administration loans, and international trade finance; and consumer loans consisting of automobile loans, secured and unsecured personal loans, home improvement loans, home equity lines of credit, overdraft protection loans, and unsecured lines of credit and credit cards. It also offers various insurance products, such as life, commercial, automobile, health, and property and casualty. The company serves the Korean-American community, as well as other communities in the multi-ethnic populations of Los Angeles County, Orange County, San Bernardino County, San Diego County, the San Francisco Bay area, and the Silicon Valley area in Santa Clara County. As of December 31, 2010, it operates a branch network of 27 full-service branch offices in California and one loan production office in Washington. Hanmi Financial Corporation was founded in 1981 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By GuruFocus]
Hanmi Financial Corporation (HAFC): President and CEO Chong Guk Kum Bought 1,821 Shares
President and CEO of Hanmi Financial Corporation (HAFC) Chong Guk Kum bought 1,821 shares on 09/20/2013 at an average price of $16.27. Hanmi Financial Corporation has a market cap of $513.615 million; its shares were traded at around $16.27 with a P/E ratio of 10.95 and P/S ratio of 3.82. The dividend yield of Hanmi Financial Corporation stocks is 0.43%.
No comments:
Post a Comment